查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418348

生物電子醫學市場報告：2030 年趨勢、預測與競爭分析

Bioelectric Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物電醫學的趨勢和預測

預計2024年至2030年全球生物電子醫療市場將以4.9%的複合年成長率成長。該市場的主要驅動力是慢性和急性健康問題發病率的增加以及老年人口的增加。全球生物電子醫學市場的未來看起來充滿希望，在心律不整、疼痛管理、感音性聽障、帕金森氏症、震顫、憂鬱症、抗治療性憂鬱症以及尿失禁和大便失禁市場都有機會。

生物電醫學市場洞察

Lucintel 預測，由於帕金森氏症以及憂鬱症和肥胖症等與生活方式相關的疾病發生率不斷上升，植入式心臟整流去顫器在預測期內仍將是最大的細分市場。

由於需要心臟心律調節器和植入式心臟整流去顫器來治療的心律不整頻率不斷增加，心律不整仍然是這個市場中最大的部分。

由於人們對尖端醫療設備的興趣日益濃厚，北美在預測期內可能仍將是最大的地區。

常問問題

Q1.市場成長預測如何？

A1. 2024年至2030年，全球生物電子醫學市場預計將以4.9%的複合年成長率成長。

Q2.影響市場成長的主要促進因素有哪些？

A2. 該市場的主要驅動力是慢性和急性健康問題發病率的增加以及老年人口的增加。

Q3.市場的主要細分市場有哪些？

A3. 生物電子醫學市場的未來看起來充滿希望，在心律不整、疼痛管理、感音性聽障、帕金森氏症、震顫、憂鬱症、抗治療性憂鬱症、癲癇、尿失禁和大便失禁市場都有機會。

Q4.市場上主要企業有哪些？

A4.主要生物電醫療公司如下。

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • Livanova
  • Biotronik
  • Electrocore
  • Sonova
  • Nevro
  • Stimwave

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測，由於帕金森氏症以及憂鬱症和肥胖等與生活方式選擇相關的疾病發生率不斷上升，植入式心臟整流去顫器在預測期內仍將是最大的細分市場。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 由於人們對尖端醫療設備的興趣日益濃厚，北美在預測期內仍將是最大的地區。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球生物電子醫療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物電子醫療市場趨勢（2018-2023）與預測（2024-2030）
  • 全球生物電子醫學市場（按產品）
    • 植入式心臟整流去顫器
    • 心臟心律調節器
    • 人工電子耳
    • 脊髓刺激設備
    • 深層腦部刺激器
    • 經皮神經刺激設備
    • 薦骨神經刺激器
    • 迷走神經刺激設備
    • 其他
  • 按類型分類的全球生物電子醫學市場
    • 植入式電氣設備
    • 非侵入性電氣設備
  • 全球生物電子醫學市場按應用
    • 心律不整
    • 疼痛管理
    • 感音性聽障
    • 帕金森氏症
    • 震顫
    • 憂鬱症
    • 抗治療性憂鬱症
    • 尿失禁和大便失禁
    • 其他
  • 按最終用途分類的全球生物電子醫學市場
    • 醫院
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球生物電子醫療市場區域分佈
  • 北美生物電醫療市場
  • 歐洲生物電子醫療市場
  • 亞太地區生物電子醫療市場
  • 其他地區生物電醫療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球生物電子醫學市場成長機會（按產品）
    • 按類型分類的全球生物電子醫學市場成長機會
    • 全球生物電子醫學市場成長機會（按應用）
    • 按最終用途分類的全球生物電子醫學市場成長機會
    • 全球生物電子醫學市場按地區成長機會
  • 全球生物電醫學市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物電子醫學市場的產能
    • 全球生物電子醫療市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • LivaNova
  • Biotronik
  • electroCore
  • Sonova
  • Nevro
  • Stimwave
簡介目錄

Bioelectric Medicine Trends and Forecast

The future of the global bioelectric medicine market looks promising with opportunities in the arrhythmia, pain management, sensorineural hearing loss, parkinson's disease, tremor, depression, treatment-resistant depressionepilepsy, and urinary and fecal incontinence markets. The global bioelectric medicine market is expected to grow with a CAGR of 4.9% from 2024 to 2030. The major drivers for this market are rising occurrence of both chronic and acute health issues and expanding demographic of elderly individuals highlights.

A more than 150-page report is developed to help in your business decisions.

Bioelectric Medicine by Segment

The study includes a forecast for the global bioelectric medicine by product, type, application, end use, and region.

Bioelectric Medicine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Implantable Cardioverter Defibrillators
  • Cardiac Pacemakers
  • Cochlear Implants
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

Bioelectric Medicine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Implantable Electroceutical Devices
  • Non-Invasive Electroceutical Devices

Bioelectric Medicine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Arrhythmia
  • Pain Management
  • Sensorineural Hearing Loss
  • Parkinson'S Disease
  • Tremor
  • Depression
  • Treatment-Resistant Depressionepilepsy
  • Urinary And Fecal Incontinence
  • Others

Bioelectric Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Others

Bioelectric Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bioelectric Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioelectric medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioelectric medicine companies profiled in this report include-

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • Livanova
  • Biotronik
  • Electrocore
  • Sonova
  • Nevro
  • Stimwave

Bioelectric Medicine Market Insights

Lucintel forecasts that implantable cardioverter defibrillators will remain the largest segment over the forecast period due to rising rates of parkinson's disease and diseases linked to lifestyle choices, such depression and obesity.

Within this market, arrhythmia will remain the largest segment due to increasing frequency of arrhythmias requiring the use of cardiac pacemakers and implanted cardioverter-defibrillators for therapy.

North America will remain the largest region over the forecast period due to increasing interest in cutting-edge medical devices.

Features of the Global Bioelectric Medicine Market

Market Size Estimates: Bioelectric medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioelectric medicine market size by various segments, such as by product, type, application, end use, and region in terms of value ($B).

Regional Analysis: Bioelectric medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, type, application, end use, and regions for the bioelectric medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioelectric medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bioelectric medicine market?

Answer: The global bioelectric medicine market is expected to grow with a CAGR of 4.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bioelectric medicine market?

Answer: The major drivers for this market are rising occurrence of both chronic and acute health issues and expanding demographic of elderly individuals highlights.

Q3. What are the major segments for bioelectric medicine market?

Answer: The future of the bioelectric medicine market looks promising with opportunities in the arrhythmia, pain management, sensorineural hearing loss, parkinson's disease, tremor, depression, treatment-resistant depressionepilepsy, and urinary and fecal incontinence markets.

Q4. Who are the key bioelectric medicine market companies?

Answer: Some of the key bioelectric medicine companies are as follows.

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cochlear
  • Livanova
  • Biotronik
  • Electrocore
  • Sonova
  • Nevro
  • Stimwave

Q5. Which bioelectric medicine market segment will be the largest in future?

Answer: Lucintel forecasts that implantable cardioverter defibrillators will remain the largest segment over the forecast period due to rising rates of Parkinson's disease and diseases linked to lifestyle choices, such depression and obesity.

Q6. In bioelectric medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing interest in cutting-edge medical devices.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioelectric medicine market by product (implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others), type (implantable electroceutical devices and non-invasive electroceutical devices), application (arrhythmia, pain management, sensorineural hearing loss, parkinson's disease, tremor, depression, treatment-resistant depressionepilepsy, urinary and fecal incontinence, and others), end use (hospitals and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bioelectric Medicine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bioelectric Medicine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bioelectric Medicine Market by Product
    • 3.3.1: Implantable Cardioverter Defibrillators
    • 3.3.2: Cardiac Pacemakers
    • 3.3.3: Cochlear Implants
    • 3.3.4: Spinal Cord Stimulators
    • 3.3.5: Deep Brain Stimulators
    • 3.3.6: Transcutaneous Electrical Nerve Stimulators
    • 3.3.7: Sacral Nerve Stimulators
    • 3.3.8: Vagus Nerve Stimulators
    • 3.3.9: Others
  • 3.4: Global Bioelectric Medicine Market by Type
    • 3.4.1: Implantable Electroceutical Devices
    • 3.4.2: Non-invasive Electroceutical Devices
  • 3.5: Global Bioelectric Medicine Market by Application
    • 3.5.1: Arrhythmia
    • 3.5.2: Pain Management
    • 3.5.3: Sensorineural Hearing Loss
    • 3.5.4: Parkinson's Disease
    • 3.5.5: Tremor
    • 3.5.6: Depression
    • 3.5.7: Treatment-resistant DepressionEpilepsy
    • 3.5.8: Urinary and Fecal Incontinence
    • 3.5.9: Others
  • 3.6: Global Bioelectric Medicine Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bioelectric Medicine Market by Region
  • 4.2: North American Bioelectric Medicine Market
    • 4.2.2: North American Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others
  • 4.3: European Bioelectric Medicine Market
    • 4.3.1: European Bioelectric Medicine Market by Product: Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
    • 4.3.2: European Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others
  • 4.4: APAC Bioelectric Medicine Market
    • 4.4.1: APAC Bioelectric Medicine Market by Product: Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
    • 4.4.2: APAC Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others
  • 4.5: ROW Bioelectric Medicine Market
    • 4.5.1: ROW Bioelectric Medicine Market by Product: Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
    • 4.5.2: ROW Bioelectric Medicine Market by Application: Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson's Disease, Tremor, Depression, Treatment-resistant DepressionEpilepsy, Urinary and Fecal Incontinence, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bioelectric Medicine Market by Product
    • 6.1.2: Growth Opportunities for the Global Bioelectric Medicine Market by Type
    • 6.1.3: Growth Opportunities for the Global Bioelectric Medicine Market by Application
    • 6.1.4: Growth Opportunities for the Global Bioelectric Medicine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Bioelectric Medicine Market by Region
  • 6.2: Emerging Trends in the Global Bioelectric Medicine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bioelectric Medicine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bioelectric Medicine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: Abbott
  • 7.3: Boston Scientific Corporation
  • 7.4: Cochlear
  • 7.5: LivaNova
  • 7.6: Biotronik
  • 7.7: electroCore
  • 7.8: Sonova
  • 7.9: Nevro
  • 7.10: Stimwave